<html><!-- #BeginTemplate "/Templates/1999 Press Releases.dwt" -->

<head>
<meta name="" content="">
<meta name="" content="">
<!-- #BeginEditable "doctitle" --> 
<title>Public Citizen</title>
<!-- #EndEditable --> 
</head>

<body text="#000000" link="#0000FF" bgcolor="#CCCC99" vlink="#0000FF" alink="#0000FF">
<div align="center">
  <center>

<table width="600" bgcolor="#FFFFFF" cellpadding="0" cellspacing="0" align="center">
<tr align="center" valign="top">
<td>
<table border="0" width="600" cellspacing="0" cellpadding="0" align="center">
<tr valign="bottom">
<td align="center" width="15">&nbsp;</td>
<td align="center" width="360"> 
<p align="left"><font face="Arial, Helvetica, sans-serif" size="3" color="#666666"><img border="0" src="../../images/wirelogo.gif" width="350" height="55" alt="NewsWire" align="bottom"> 
</font>
</td>
<td align="center" width="225" valign="middle"> 
     
<p align="center"><font face="Arial, Helvetica, sans-serif" size="3" color="#666666">
<font color="#000066"><font size="1"><br>
</font></font></font><font face="Arial, Helvetica, sans-serif" size="3" color="#666666"><font color="#000066">
<script language="JavaScript">
var now=new Date();
var monthName=now.getMonth()+1;
var dayName=now.getDay()+1;
var dayNumber = now.getDate();
if(dayName==1)Day="Sunday";
if(dayName==2)Day="Monday";
if(dayName==3)Day="Tuesday";
if(dayName==4)Day="Wednesday";
if(dayName==5)Day="Thursday";
if(dayName==6)Day="Friday";
if(dayName==7)Day="Saturday";
if(monthName==1)Month="January";
if(monthName==2)Month="February";
if(monthName==3)Month="March";
if(monthName==4)Month="April";
if(monthName==5)Month="May";
if(monthName==6)Month="June";
if(monthName==7)Month="July";
if(monthName==8)Month="August";
if(monthName==9)Month="September";
if(monthName==10)Month="October";
if(monthName==11)Month="November";
if(monthName==12)Month="December";
document.open();
document.write( Day + "<br>"
 + Month + " " + dayNumber);
</script>
, 2000</font></font><font color="#006600" size="2" face="Arial, Helvetica, sans-serif"> 
</font>
</td>
</tr>
<tr valign="middle" align="left" bgcolor="#F4F4E1">
<td height="25"><font color="#000000"></font></td>
<td bgcolor="#F4F4E1" height="25"> 
<p align="left"><font color="#000000" size="1" face="Arial"> <font size="2" face="Arial, Helvetica, sans-serif" color="#006600"><b>Latest news from America's Progressive Community</b></font></font>
</td>
<td align="center" bgcolor="#F4F4E1" height="25"><font face="Arial, Helvetica, sans-serif" size="3" color="#000000"><font size="1"><a href="http://www.commondreams.org/search.html">Search</a> | <a href="http://www.commondreams.org/email.htm">Sign Up</a> | <a href="http://www.commondreams.org/privacy.htm">Privacy</a> </font></font></td>
</tr>
</table>
<table border="0" cellpadding="3" cellspacing="0" width="600">
<tr bgcolor="#E8E8E8" align="right" valign="middle"> 
<td width="600" colspan="5" height="25"> 
     
<div align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>&nbsp;&nbsp;<a href="http://www.commondreams.org/">NewsCenter</a> 
&gt; <a href="http://www.commondreams.org/newswire.htm">NewsWire</a> </b></font><b><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&gt; 
For Immediate Release&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b></div>
</td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#E8E8E8" width="15" rowspan="7"> <font face="Arial, Helvetica, sans-serif" size="2"><a href="http://www.commondreams.org/wirearchive.htm">
</a></font> 
<p align="left"><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font></p>
<p align="left">&nbsp;</p>
<p>
</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="20" rowspan="7">&nbsp;</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="530">
<div align="left"><font face="Arial, Helvetica, sans-serif" size="2"><a href="http://www.commondreams.org/share.htm"><br>
<img src="../../images/email.gif" width="25" height="14" alt="Email" border="0">&nbsp;Share This Article With A Friend</a></font></div>
</td>
<td valign="top" align="left" bgcolor="#FFFFFF" width="20" rowspan="7">&nbsp;</td>
<td valign="top" align="left" bgcolor="#E8E8E8" width="15" rowspan="7">&nbsp; </td>
</tr>
<tr> 
<td valign="top" align="left" width="530" bgcolor="#FFFFFF"><!-- #BeginEditable "Contact" --> 
<div align="left"><font size="2" face="Arial, Helvetica, sans-serif"><font color="#000000">JUNE 
30, 1999&nbsp;&nbsp;5:19 PM<br>
<strong>FOR IMMEDIATE RELEASE<br>
</strong>CONTACT:<b> </b></font><b><a href="http://www.citizen.org/">Public Citizen</a></b><br>
</font></div>
<!-- #EndEditable --></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="530"></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="530"><font size="4" face="Arial, Helvetica, sans-serif"><b><!-- #BeginEditable "Header" --><font size="4" face="Arial, Helvetica, sans-serif"><b>Aggressive 
Lobbying Behind Claritin Patent Extension Bill Could Cost Consumers $1.6 to $3.2 
Billion; Public Citizen Report Tallies Growth in Schering-Plough's Lobbying </b></font><!-- #EndEditable --></b></font></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="530">&nbsp; 
</td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="530"><!-- #BeginEditable "Body" --><font size="2" face="Arial, Helvetica, sans-serif"><font color="#000000">WASHINGTON 
- June 30 - Public Citizen issued a<a href="http://www.citizen.org/congress/drugs/splobby.htm"> 
report </a>today detailing Schering-Plough's escalating lobbying expenditures 
as the company mounts an aggressive campaign in Congress for H.R. 1598/S. 1172 
to gain a special-interest patent extension for its allergy drug Claritin. The 
patent extension could cost consumers $1.6 billion - $3.2 billion more over a 
three-year period. 
<p><font size="2">&quot;The high cost of prescription drugs is becoming a public 
health crisis in the United States,&quot; Public Citizen President Joan Claybrook 
said. &quot;The public policy question that should be before Congress is how to 
make medicines more -- rather than less -- affordable. Consumers are already paying 
through the nose for brand name drugs like Claritin. Congress should be looking 
for ways to bring costs down, not rewarding pharmaceutical industry lobbyists 
by extending monopoly price protection.&quot;</font></p>
<p><font size="2">The report shows that between 1996 and 1998, Schering-Plough's 
lobbying expenditures more than doubled, from $1.9 million in 1996 to $4.3 million 
in 1998. The number of outside lobbying firms retained to lobby on the patent 
extension issue also doubled, from five to 10. While Schering-Plough ranks only 
ninth in sales among pharmaceutical companies, in 1998 the company was fourth 
highest in lobbying expenditures, moving up from its seventh-place rank in 1997.</font></p>
<p><font size="2">In addition to such powerful registered lobbyists as former 
Senate Majority Leader Howard Baker (R-Tenn.), former Sen. Dennis DeConcini (D-Ariz.), 
and Democratic power brokers Peter Knight and Richard Ben-Veniste, Schering-Plough 
has also benefited from the support of C. Everett Koop, M.D. On the Hill, Koop 
has actively promoted the Claritin patent extension bill by writing an April 29, 
1999, (the day after the bill was introduced) letter to all representatives in 
support H.R. 1598 and by appearing at a June 10, 1999, forum in the Capitol organized 
to showcase H.R. 1598 and the proposed Claritin patent extension.</font></p>
<p><font size="2">Only through a June 20, 1999 story in New Jersey&#146;s <i>The 
Star-Ledger</i> did it become widely known in Washington that Schering-Plough 
had made a $1 million donation to the Koop Foundation, and that the company advertises 
on Koop's website.</font></p>
<p><font size="2">&quot;A $1 million grant from a drug company followed by this 
kind of lobbying activity is a serious conflict of interest,&quot; said Sidney 
M. Wolfe, M.D., director of Public Citizen's Health Research Group. &quot;It looks 
like America has a new &#145;Company Doctor.&#146;&quot;</font></p>
<p><font size="2">&quot;This bill is moving because of Schering-Plough's aggressive 
lobbying, not because of its merits,&quot; Claybrook said. Noting that the House 
Judiciary Subcommittee on Courts and Intellectual Property had scheduled a July 
1, 1999 hearing on H.R. 1598, she questioned why this special interest retroactive 
legislation deserved Congress' attention. </font></p>
<p><font size="2">The Claritin patent extension would cost consumers $1.6 billion 
to $3.2 billion over three years. Claritin's worldwide sales were $2.2 billion 
in 1998, accounting for 28 percent of Schering-Plough's total. The company had 
$1.8 billion in net income on sales, a 22 percent profit rate. According to Public 
Citizen's estimate, Schering-Plough has already earned $1.3 billion in profits 
on Claritin, and is expected to earn another $2.2 billion before the drug's patent 
expires in 2002. New product formulations and licensing agreements extend some 
patent protection for the #1 advertised drug in America to 2014.</font></p>
</font></font><FONT SIZE=2>
<P align="center"><font face="Arial, Helvetica, sans-serif" size="2">###</font></P>
</FONT><!-- #EndEditable --></td>
</tr>
<tr> 
<td valign="top" align="left" bgcolor="#FFFFFF" width="530"><font face="Arial" size="2" color="#000000">&nbsp; 
</font></td>
</tr>
<tr bgcolor="#E8E8E8"> 
<td valign="top" align="center" width="600" colspan="5" height="15">

<div align="center"><small><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Common Dreams <a href="http://www.commondreams.org/">NewsCenter</a></b>&nbsp;is a non-profit news service<br>
 providing breaking news and views for the Progressive Community.</font></small>
</div>
<p align="center"><font face="Verdana, Arial, Helvetica, sans-serif" size="1"><small>The 
press release posted here has been provided to Common Dreams NewsWire by  
one of the many progressive organizations who make up <a href="http://www.commondreams.org/community.htm">America's Progressive Community</a>. 
If 
you wish to comment on this press release or would like more information, 
please contact the organization  directly.<br>
 
</small></font><font size="1" face="Arial">*all times Eastern US (GMT-5:00)</font><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font><font face="Arial, Helvetica, sans-serif" size="2"><small><br>
<br>
</small><b><font size="4">Making News?</font></b><br>
E-mail&nbsp;us your news release! <a href="mailto:news@newscenter.org">news@newscenter.org</a></font><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font></p>
<div align="center">
<center>
</center>
</div>
<div align="center">
<center>
<font face="Arial, Helvetica, sans-serif" size="3"><b><a href="http://www.commondreams.org/">NewsCenter</a> 
| <a href="http://www.commondreams.org/newswire.htm">NewsWire</a><br>
 <font face="Arial, Helvetica, sans-serif" size="2"><a href="http://www.commondreams.org/search.html"><font size="1">Search</font></a><font size="1"> | <a href="http://www.commondreams.org/contactingus.htm">Contacting Us</a></font></font></b></font><font size="1"><b><font face="Arial, Helvetica, sans-serif"> | <a href="http://www.commondreams.org/email.htm">Sign-Up</a> | <a href="http://www.commondreams.org/privacy.htm">Privacy</a> </font></b></font><b><font face="Arial, Helvetica, sans-serif" size="2"><br>
</font></b>
</center>
</div>
<p align="left"><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font>
<div align="center"><font face="Arial, Helvetica, sans-serif" size="2"><i>Tell Us What You Think:</i> 
 <a href="mailto:editor@newscenter.org">editor@newscenter.org 
</a><br>
 
</font><font face="Arial, Helvetica, sans-serif" size="1">
</font> 
 


</div>
<p align="center">
<font face="Arial, Helvetica, sans-serif" size="1">© Copyrighted 1997-2000
 
All Rights Reserved. Common Dreams. www.commondreams.org</font></p>
<p align="left"><font face="Arial, Helvetica, sans-serif" size="2"><small>
</small></font>
</td>
</tr>
</table>
<div align="center"></div>
</td>
</tr>
</table>

</center>
</div>
<p align="center">&nbsp;</p>
</body>

<!-- #EndTemplate --></html>
